Australian pharma and government work together on supply issues

Pharma trade body Medicines Australia will continue to manage shortages stemming from the COVID-19 pandemic in coordination with the Generic Biosimilar Medicines Association (GBMA).

The authority to work together to manage medicine supplies comes via  an authorization from Australian authorities, confirmed by the country’s antitrust watchdog, the ACCC.

The Federal government will work with Medicines Australia and the GBMA to continue to implement a coordinated strategy to ensure there is no disruption to “essential medicines and related devices.”